Skip to main content
FinSpry Logo
FinSpry
ORGO logo
ORGO
(NASDAQ)
Organogenesis Holdings Inc.
$2.24-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Organogenesis Holdings (ORGO) Stock Price & Financial Analysis

Organogenesis Holdings Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.21 - $2.29
52-Week High$7.08
52-Week Low$2.26
Open$2.28
Volume505.02K
Average Volume (3M)505.02K
Market Cap291.76M
Shares Outstanding130.25M
P/E Ratio (TTM)8.12
Forward P/E4.12
Price to Sales (P/S)0.53
Price to Book (P/B)0.69
EV/EBITDA4.44
Revenue (TTM)563.57M
Net Income (TTM)37.03M
Free Cash Flow (TTM)-24.46M
EPS (TTM)$0.28
Profit Margin6.57%
Operating Margin11.64%
Return on Equity (ROE)8.53%
Debt to Equity0.31
50-Day MA$3.28
200-Day MA$4.28
52-Week Change-46.03%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Organogenesis Holdings

What is the current stock price for ORGO?

As of the latest trading session, ORGO stock trades at $2.24. The 52-week range is $2.26–$7.08, with a day range of $2.21–$2.29.

What is the P/E ratio for ORGO?

Organogenesis Holdings's trailing P/E ratio is 8.1, meaning investors pay $8.1 for every $1 of annual earnings. The forward P/E is 4.1, reflecting analyst expectations for future earnings. Organogenesis Holdings operates in the Healthcare sector.

Does ORGO pay dividends?

Organogenesis Holdings does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ORGO?

Based on 1 analyst, the consensus for ORGO is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ORGO?

Organogenesis Holdings's market capitalization is $291.8M, classifying it as a micro-cap company. Organogenesis Holdings operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.